Home » Drug Information » FDA Approved Drugs » 1996
Medical Areas: Immunology | Family Medicine
View By:YearCompanyConditionsTherapeutic AreasDrug Names
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Access Pharmaceuticals
Approval Status: Approved May 1996
Treatment Area: canker sores
Apthasol has been approved for the treatment of signs and
symptoms of canker sores.
Dentists are now able to prescribe the topical oral paste for
subjects who have a recurring problem with apthous ulcers. The
paste is applied four times a day and may sting or burn upon
application. It is not yet known how Apthasol works, although it is
thought it inhibits inflammation and offers protection as a wound
Fifteen percent of the worldwide population suffer from canker
sores. In the United States, canker sores result in more than
7,000,000 subjects visits to medical practitioners per year. Canker
sores are considered a nuisance and painful, but no real threat.
Any sore that persists for more than two weeks, especially one that
isn't painful, should be examined by your dentist.